MSD is gearing up to file antibiotic Zerbaxa on both sides of the Atlantic for certain forms of pneumonia on the success of a late-stage trial backing its safety and efficacy. More: MSD to file antibiotic Zerbaxa for pneumonia Source:
read moreThe production of new cell and gene therapies at a manufacturing site in Stevenage – for use in health services around the world – has been given the green light by the Medicines and Healthcare products Regulatory Agency (MHRA). More:
read moreMerck KGaA and Pfizer say they intend to seek US approval of a combination of Bavencio and Inlyta for kidney cancer on the back of progression-free survival data from a late-stage trial. More: Merck, Pfizer intend to file Bavencio, Inlyta
read moreNo question, the lung cancer field is hot—and full of new drugs and combos. But there’s a dearth of treatments designed for early-stage disease, and Johnson & Johnson is looking to crowdsourcing to bring in new ideas. More: Johnson &
read more© 1994 - 2026 B.M. Pharmaceuticals